Nautilus Biotechnology, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Nautilus Biotechnology, Inc. (NAUT) had Deferred Tax Assets, Operating Loss Carryforwards of $56.65 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $56.65M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $32.74M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $21.62M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.40M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $56.65M 10-K · filed 2026-02-26 |
| 2024-12-31 | $32.74M 10-K · filed 2026-02-26 |
| 2023-12-31 | $21.62M 10-K · filed 2025-02-27 |
| 2022-12-31 | $12.40M 10-K · filed 2024-02-28 |
| 2021-12-31 | $7.32M 10-K · filed 2023-02-23 |
| 2020-12-31 | $3.35M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |